Pulmonary Langerhans cell histiocytosis
Disease description
A group of disorders resulting from the abnormal proliferation of and tissue infiltration by LANGERHANS CELLS which can be detected by their characteristic Birbeck granules (X bodies), or by monoclonal antibody staining for their surface CD1 ANTIGENS. Langerhans-cell granulomatosis can involve a single organ, or can be a systemic disorder. Year introduced: 1990(1975)
Source: MeSHReferences 1
Download references
Title
with link to reference page |
Journal | Year | Authors |
---|---|---|---|
Separating smoking-related diseases using NMR-based metabolomics of exhaled breath condensate. | J. Proteome Res. | 2013 |
G. de Laurentiis, D. Paris, D. Melck, P. Montuschi, M. Maniscalco, A. Bianco, M. Sofia, A. Motta
J. Proteome Res. 2013 Mar;12(3):1502-11. PubMed:23360153 |
Compounds 7
Download compoundsAcetate | PubChem CID: 175 |
Ethanol | PubChem CID: 702 |
1-methylimidazole | PubChem CID: 1390 |
Isopropanol | PubChem CID: 3776 |
Isobutyric acid | PubChem CID: 6590 |
Propanoate | PubChem CID: 104745 |
Methanol | PubChem CID: 101954077 |
MeSH information
MeSH ID | D006646 |
MeSH name | Histiocytosis, Langerhans-Cell |